NEU neuren pharmaceuticals limited

Ann: Response to Appendix 4C Query, page-33

  1. 19 Posts.
    lightbulb Created with Sketch. 2
    sillase

    As the NEU market is absolutely under institutional control, in the light of the latest news and short-term expectations, executives' remuneration for achieving results will mark the price on the market. I am still confident about the allocation of 50 million shares to three executives (Pilcher, Shawe and Blower) authorized and deposited in a Guarantee Fund. These options have maturities as to vesting and performance conditions. For the first two executives, the vesting has already matured, while the Blower is talking about it in September. For all, there are three rules for assignment ie advancement of at least one pipeline in phase 2B or Three, a partnership and 75% value In addition to the value of market shares calculated in the thirty days since the conditions are checked, this means in numerical terms that the price per share, because there is the maturation of ordinary shares to executives, both for the first two cases of 0.146 and for The third 0.161 in September. These are the numbers that the market should express between late May and late September next to reason of cause and for primary management interest. All indicated in the last report at the end of March on pages 17 and 18.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.10
Change
-0.800(5.76%)
Mkt cap ! $1.629B
Open High Low Value Volume
$13.95 $13.96 $12.88 $9.534M 725.6K

Buyers (Bids)

No. Vol. Price($)
1 266 $13.10
 

Sellers (Offers)

Price($) Vol. No.
$13.15 1619 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.